title: Psilocybin: promising results in double-blind trials require confirmation by real-world evidence.
authors.affiliation: Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK.
authors.forename: Alasdair
authors.initials: A
authors.lastname: Breckenridge
authors.affiliation: Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands D.E.Grobbee@umcutrecht.nl.
authors.forename: Diederick E
authors.initials: DE
authors.lastname: Grobbee
mesh_terms: D000339:Affect; D004311:Double-Blind Method; D006213:Hallucinogens; D006801:Humans; D011562:Psilocybin
chemical_list: D006213:Hallucinogens; D011562:Psilocybin